An unfolded protein found in human milk shows promise in early clinical trials to treat bladder cancer.

A clever approach to modifying already existing cancer therapies may be a game changer for treating metastatic breast cancer.

An unexpected and unprecedented finding may lead to improved cancer therapies.

Glucometers are easy-to-use, cheap, and highly scalable. And they are 100 percent accurate at detecting SARS-CoV-2.

Tiny but powerful nanobodies may be the innovation that snuffs out the pandemic.

Skin symptoms are often the first, or only, symptom of COVID-19.

Transplanted CAR stem cells persisted long term and showed multilineage engraftment in tissues that harbor HIV.

Researchers developed a new CAR T-cell therapy that targets specific growth factor receptors in glioblastoma to eliminate brain tumors.

Pairing CARs with a synthetic receptor makes T cells more lethal tumor killers.

Scientists in cannabis extraction laboratories are bravely pioneering a new field of agro-chemical engineering.

Scientists uncover the promise of mesenchymal stem cells (MSCs), also known as medicinal signaling cells, to modulate the immune system and regenerate tissue.

A conversation with Dirk Ahlbrecht from Sartorius about where lab balance technology is headed in the 21st century

Cancer cells develop resistance to targeted therapies, and their inherent functional heterogeneity makes it difficult for researchers to understand and characterize these resistance mechanisms. IsoPlexis' single-cell proteomics is helping researchers overcome resistance to targeted inhibitors, leading to better strategies and combination therapies.

Scientists rely on synthetic biology and cell-free expression systems for developing novel approaches to combat the pandemic.

Arbor Biosciences is offering free SARS-CoV-2 myBaits kits to all researchers.  

Given its legal status as a controlled substance, researchers, producers, and developers still must be aware of a considerable number of regulatory guidelines and practices governing the cannabis industry.

Tully Stroud, Chief Scientific Officer for Elite Molecular Labs, talks about the growing field of cannabis extraction and refinement. 

Leonardo Ferreira, a postdoctoral fellow at the University of California, San Francisco, discusses the application of single cell proteomics data to understanding the function and therapeutic potential of genetically engineered regulatory T cells.

Vladimir Senyukov, Director of BioAnalytical Development at Precision Biosciences, talks about investigating T-cell cytokine production using single cell proteomics in order to unlock the therapeutic potential of allogeneic CAR-T cells.